Saxagliptin tablets bulk supplier for pharma manufacturers

Saxagliptin Tablets 2.5 mg, 5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2.5 mg, 5 mg

Reference Brands: Onglyza®(US & EU)

Category: Diabetes

Saxagliptin inhibits DPP-4, enhancing incretin hormones to boost insulin secretion and reduce glucagon levels in a glucose-dependent manner. Benefits include improved glycemic control, low hypoglycemia risk, weight neutrality, and once-daily oral dosing. Suitable as monotherapy or in combination therapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Saxagliptin oral tablets, marketed as Onglyza®, are FDA-approved in the USA and EMA-authorized in the EU for managing type 2 diabetes. Also available in combination with metformin as Kombiglyze XR® (USA) and Komboglyze® (EU), these DPP-4 inhibitors require full compliance with GMP, pharmacovigilance, and post-marketing safety reporting. US regulations mandate NDA approval under 21 CFR, with heart failure warnings. In the EU, approval follows the centralized procedure with CTD submissions and Risk Management Plans (RMPs). For compliant sourcing, regulatory support, or B2B pharmaceutical trade, visit PharmaTradz.com – your trusted partner in global pharma solutions.

Saxagliptin Tablets — third party manufacturing & bulk supply

Saxagliptin Tablets 2.5 mg, 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Saxagliptin Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Saxagliptin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Saxagliptin Tablets →

Back to Listing

Frequently Asked Questions

Saxagliptin tablets is listed as Tablets in 2.5 mg, 5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Saxagliptin tablets is referenced against Onglyza®(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.